Michael Amoroso
2021 - Abeona Therapeutics
In 2021, Michael Amoroso earned a total compensation of $3.1M as Former President and Chief Executive Officer at Abeona Therapeutics, a 104% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,589,910 |
|---|---|
| Salary | $450,477 |
| Stock Awards | $1,013,000 |
| Other | $11,600 |
| Total | $3,064,987 |
Amoroso received $1.6M in option awards, accounting for 52% of the total pay in 2021.
Amoroso also received $450.5K in salary, $1M in stock awards and $11.6K in other compensation.
Rankings
In 2021, Michael Amoroso's compensation ranked 4,344th out of 12,415 executives tracked by ExecPay. In other words, Amoroso earned more than 65.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,344 out of 12,415 | 65th |
Division Manufacturing | 1,793 out of 5,508 | 67th |
Major group Chemicals And Allied Products | 754 out of 2,378 | 68th |
Industry group Drugs | 673 out of 2,099 | 68th |
Industry Pharmaceutical Preparations | 478 out of 1,549 | 69th |
Source: SEC filing on April 13, 2023.
Amoroso's colleagues
We found three more compensation records of executives who worked with Michael Amoroso at Abeona Therapeutics in 2021.
News
PRECISION BIOSCIENCES CEO Michael Amoroso's 2023 pay falls 53% to $2M
April 25, 2024
PRECISION BIOSCIENCES CEO Michael Amoroso's 2022 pay falls 27% to $4.4M
March 23, 2023
Abeona Therapeutics CEO Michael Amoroso's 2021 pay jumps 104% to $3.1M
July 11, 2022
PRECISION BIOSCIENCES CEO Michael Amoroso's 2021 pay jumps 299% to $6M
March 29, 2022